Levels Diagnostics was awarded the MIT R&D grant by the Provide of South Holland. Together with Omnigen and SG papertronics the consortium will develop a test that can quickly identify early signs of liver damage in patients.
Bilthoven and Maastricht, the Netherlands, 6 January 2021 – Intravacc, a world leader in translational research and development of vaccines, and Cristal Therapeutics, a technology leader in enabling safer and more effective therapeutics, to
We are very pleased to announce that The Netherlands Organization for Scientific Research (NWO) has granted the Take-Off Phase II loan (€250.000) for the further development of our lead compound, Microlyse.
BIMINI Biotech, an innovative therapeutics startup that develops new cancer drugs, has secured an investment of €200,000 from proof-of-concept fund UNIIQ to further develop its technology.
TargED (formerly IOVA) closes seed investment and partners with UMC Utrecht for the development of Microlyse - a next-generation thrombolytic clot-busting drug
TargED Biopharmaceuticals, a biotech spin-
“With its commitment to enhancing treatment options for the most urgent medical needs, GlycoCheck and Microvascular Health Solutions is moving the needle in microvascular health and ensuring quality care for all,” reported MedTech Outlook
Spin-off van de TU Delft BIOND Solutions (Bi/ond) ontwikkelde een microchip om menselijke cellen en weefsels op te kweken en te voorzien van zuurstof en voedingsstoffen.